lncRNA KCNQ1OT1 reverses the effect of sevoflurane on hepatocellular carcinoma progression via regulating the miR-29a-3p/CBX3 axis

Sevoflurane (SEVO) is widely applied as an anesthetic, which exerts antitumor capacity in various cancers, including hepatocellular carcinoma (HCC). Previous studies indicated that long non-coding RNA KCNQ1 opposite strand/antisense transcript 1 (KCNQ1OT1) was upregulated, while microRNA-29a-3p (miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Weifu, Li, Hui, Shang, Shuo, Liu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130105/
https://www.ncbi.nlm.nih.gov/pubmed/34008749
http://dx.doi.org/10.1590/1414-431X2020e10213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130105/
https://www.ncbi.nlm.nih.gov/pubmed/34008749
http://dx.doi.org/10.1590/1414-431X2020e10213

Ejemplares similares